Leader in vomiting and nausea treatment, Vonau Flash® gains new mint flavor

Portal Sindusfarma | 08/19/2020
Fonte: Portal Sindusfarma
Biolab Farmacêutica brings a new version of the Vonau Flash drug to the Brazilian market, which is now also offered in mint flavor.
 
Having ondansetron as an active ingredient, Biolab's antiemetic is indicated for the prevention and treatment of vomiting and nausea caused by different factors.
 
Vonau Flash® is the result of a partnership between Biolab and the University of São Paulo (USP), which hold its patent. The product was innovative, transforming the market and exposing patients to fewer adverse effects (compared to other antiemetic molecules). It dissolves quickly and easily, without the need for water intake, which is a great advantage, because water can be an emetic agent for those who are vomiting and nauseated.
 
Vonau Flash® Mint is available in drugstores throughout Brazil in 4 mg and 8 mg packs with 10 tablets in Flash format (orodispersible patent).
 
 
Important information
 
Vonau Flash® (ondansetron hydrochloride), 4 mg and 8 mg, oral disintegration tablet. ADULT AND PEDIATRIC USE OVER 2 YEARS OF AGE. INDICATIONS: prevention and treatment of nausea and vomiting in general. CONTRAINDICATIONS: patients with hypersensitivity to the components of the formula. Children under 2 years of age. WARNINGS AND PRECAUTIONS: Should not be used in place of nasogastric aspiration. Phenylketonurics and nursing mothers must use with caution. Pregnant women should seek medical advice prior to use. Patients with severe liver failure are not recommended to exceed the daily dose of 8 mg. DRUG INTERACTIONS: inducers or inhibitors of cytochrome P450 enzymes. Adverse reactions: headache, constipation, fatigue, diarrhea, skin rash. For more information on unusual reactions, refer to the Vonau Flash® package insert. DOSAGE: Adult use: 16 mg ondansetron (two 8 mg tablets).
 
Pediatric use: For patients older than 11 years of age, a dose of 4 to 8 mg of ondansetron (one to two 4 mg tablets) is recommended. For children between 2 and 11 years of age, a dose of 4 mg of ondansetron (one 4 mg tablet) is recommended. Refer to the Vonau Flash® package insert about the need for special dose/population adjustment. Registration at the Ministry of Health – No. 1.0974.0194. PRESCRIPTION ONLY MEDICATION. IF
 
SYMPTOMS PERSIST, SEE YOUR DOCTOR. For more information, refer to the product's full package insert or contact the Biolab Customer Service – SAC 0800-724-6522 – e-mail: faleconosco@biolabfarma.com.br.
Learn more
arrow_backward See more articles
Customer Service 0800 724 6522
faleconosco@biolabfarma.com.br
Be connected